Theresa M. Medina, MD, on Treating Cutaneous Squamous Cell Carcinoma With Cemiplimab-rwlc

Posted: Monday, September 16, 2019

What is the future role of systemic therapies such as cemiplimab-rwlc in the neoadjuvant or adjuvant treatment of advanced cutaneous squamous cell carcinoma?

Sections

NCCN Resources

360 HUB
About
Contact
Disclaimer
Disclosures
Privacy Policy
Terms Of Use

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.